Bio & Pharma
Seegene's COVID-19 diagnostic product wins Product of the Year Award
The S.Korean diagnostic kit maker has developed Allplex SARS-CoV-2 Assay which detects 4 different target genes
By Dec 16, 2022 (Gmt+09:00)
1
Min read
Most Read
S.Korea's LS Materials set to boost earnings ahead of IPO process
Galaxy Ring, new foldables set to steal the show at Samsung Unpacked Paris
POSCO gears up for carbon-free steelmaking with hydrogen
SK Inc. in talks to sell Pharmteco’s US CDMO plant to Novo Nordisk
South Korea sets sights on fostering EDA tech to win HBM chip war
Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum Asia Excellence Awards on Dec 2.
BioSpectrum Asia is a media platform and market research firm that covers the pharmaceutical and biotech industries in the region.
"We will contribute to the healthy life of mankind by strengthening R&D to enable faster and more accurate diagnosis of infectious diseases and genetic diseases, and widening the range of molecular diagnostics by producing excellent products," said Seegene CEO Chun Jong-Yoon.
"As a global leader in molecular diagnostics, we will continue to monitor and respond to future pandemics," he added.
In addition, Lunit, a Seoul-based medical AI company, received the Startup of the Year award.
Write to Jeong Min Nam at peux@hankyung.com
More to Read
-
BiotechSeegene develops one-stop COVID-19 testing lab on wheels; eyes MENA expansion
Jun 25, 2021 (Gmt+09:00)
2 Min read
Comment 0
LOG IN